Dr. Dennis F. Kellar , MD
Internal Medicine - Pulmonary Disease • Algonquin, IL
1340 Ryan Pkwy
Algonquin, IL 601024527
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
Dr. Dennis Kellar is listed in NPPES under Internal Medicine - Pulmonary Disease.
-
NPI assigned on August 30, 2006; this date does not establish years in practice.
-
Published CMS data list 3,949 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- 99215 — Established patient outpatient office visit: 777 service units.
- 94726 — Test to determine lung volumes using sensors: 595 service units.
- 94729 — Test to examine how well the lungs exchange gases: 590 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 21 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 2,152 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter) — 440 prescription fills, including refills.
- Montelukast Sodium — 283 prescription fills, including refills.
- Prednisone — 217 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 35 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Medicare Part B services than 95% of clinicians listed under Internal Medicine - Pulmonary Disease in Illinois (2024, 420 clinicians with data). Median for this group: 896. Middle half: 358 to 1,804.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 6,668 in 2020 to 3,949 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020–2024.
Practice Location & Contact Primary Location
1340 Ryan Pkwy
Algonquin, IL 601024527
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
CMS Doctors and Clinicians lists 1 group name: Northwest Pulmonary And Sleep Medicine Sc. See the list
Source: CMS Doctors and Clinicians National Downloadable File, release date unavailable.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
1997
What Public CMS Data Show
Internal Medicine - Pulmonary Disease: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
977 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $373,797 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $284,532 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
3,515 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$2,291,478 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $1,917.93 across 81 records.
By nature of payment
- Food and Beverage: $1,917.93 across 81 records.
Reporting-company totals (3 largest of 17)
- AstraZeneca Pharmaceuticals LP: $455.50 across 13 records.
- Sanofi and Genzyme US Companies: $361.06 across 15 records.
- GlaxoSmithKline, LLC.: $331.67 across 23 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
29 years (graduated 1997)
CMS Doctors and Clinicians data list 1997 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2006
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
Telehealth (some services)
Recent Medicare claims show this clinician provided some services by telehealth, such as a video or phone visit.
You may be able to have some visits without going to the office. Ask which visits can be done by telehealth.
What this does not show: Telehealth (some services)
It does not mean all services are offered by telehealth, or that telehealth is covered by your plan.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Kellar has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Kellar as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Algonquin and Illinois
Billing and prescribing volume is not a quality rating.
Medicare Part B services
More Medicare Part B services than 95% of clinicians listed under Internal Medicine - Pulmonary Disease in Illinois (2024, 420 clinicians with data). Median for this group: 896. Middle half: 358 to 1,804.
Too few clinicians listed under Internal Medicine - Pulmonary Disease in Algonquin have Medicare Part B data for 2024 to compare.
Medicare-allowed amount
A higher Medicare-allowed amount than 95% of clinicians listed under Internal Medicine - Pulmonary Disease in Illinois (2024, 420 clinicians with data). Median for this group: $92,004. Middle half: $41,661 to $177,106.
Too few clinicians listed under Internal Medicine - Pulmonary Disease in Algonquin have Medicare Part B data for 2024 to compare.
Paid by Medicare
A higher Medicare payment amount than 95% of clinicians listed under Internal Medicine - Pulmonary Disease in Illinois (2024, 420 clinicians with data). Median for this group: $69,928. Middle half: $31,974 to $135,512.
Too few clinicians listed under Internal Medicine - Pulmonary Disease in Algonquin have Medicare Part B data for 2024 to compare.
Medicare Part D prescriptions
More Part D prescriptions than 80% of clinicians listed under Internal Medicine - Pulmonary Disease in Illinois (2024, 406 clinicians with data). Median for this group: 763. Middle half: 184 to 1,610.
Too few clinicians listed under Internal Medicine - Pulmonary Disease in Algonquin have Medicare Part D data for 2024 to compare.
Part D drug cost
A higher Part D drug cost than 90% of clinicians listed under Internal Medicine - Pulmonary Disease in Illinois (2024, 406 clinicians with data). Median for this group: $391,081. Middle half: $53,106 to $979,710.
Too few clinicians listed under Internal Medicine - Pulmonary Disease in Algonquin have Medicare Part D data for 2024 to compare.
2 active clinicians are listed under Internal Medicine - Pulmonary Disease with a practice address in Algonquin, IL (617 in Illinois).
Addresses are self-reported to NPPES and may be out of date.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services decreased 41% from 6,668 in 2020 to 3,949 in 2024.
- 2020: 6,668
- 2021: 3,474
- 2022: 3,841
- 2023: 4,524
- 2024: 3,949
-
Medicare-allowed amount
Medicare-allowed amount decreased 34% from $566,051 in 2020 to $373,797 in 2024.
- 2020: $566,051
- 2021: $308,207
- 2022: $347,324
- 2023: $416,848
- 2024: $373,797
-
Paid by Medicare
Paid by Medicare decreased 35% from $436,263 in 2020 to $284,532 in 2024.
- 2020: $436,263
- 2021: $235,622
- 2022: $268,268
- 2023: $318,858
- 2024: $284,532
-
Medicare Part D prescriptions
Medicare Part D prescriptions decreased 38% from 3,473 in 2020 to 2,152 in 2024.
- 2020: 3,473
- 2021: 2,972
- 2022: 3,293
- 2023: 2,566
- 2024: 2,152
-
30-day fills
30-day fills decreased 39% from 5,731 in 2020 to 3,515 in 2024.
- 2020: 5,731
- 2021: 4,946
- 2022: 5,343
- 2023: 4,309
- 2024: 3,515
-
Part D drug cost
Part D drug cost decreased 29% from $3,214,546 in 2020 to $2,291,478 in 2024.
- 2020: $3,214,546
- 2021: $3,586,994
- 2022: $3,961,231
- 2023: $3,275,543
- 2024: $2,291,478
-
Industry payments (Open Payments)
Industry payments (Open Payments) increased 20% from $1,593.13 in 2021 to $1,917.93 in 2025.
- 2021: $1,593.13
- 2022: $1,530.56
- 2023: $2,270.28
- 2024: $1,638.87
- 2025: $1,917.93
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 81 records totaling $1,917.93.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
FASENRA | General | $120.50 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
FASENRA | General | $116.91 |
| JAZZ PHARMACEUTICALS INC. |
Food and Beverage
In-kind items and services
|
XYWAV | General | $39.53 |
| Baxter Healthcare |
Food and Beverage
In-kind items and services
|
Hillrom - Vest System Model 105 Home Care | General | $37.07 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $36.31 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $35.71 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $35.20 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $35.19 |
| Axsome Therapeutics, Inc. |
Food and Beverage
In-kind items and services
|
Sunosi | General | $34.13 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $33.99 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $33.19 |
| Takeda Pharmaceuticals U.S.A., Inc. |
Food and Beverage
In-kind items and services
|
GLASSIA | General | $33.01 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $31.79 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $31.64 |
| Axsome Therapeutics, Inc. |
Food and Beverage
In-kind items and services
|
Sunosi | General | $30.92 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $30.11 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $29.51 |
| Takeda Pharmaceuticals U.S.A., Inc. |
Food and Beverage
In-kind items and services
|
GLASSIA | General | $29.35 |
| Axsome Therapeutics, Inc. |
Food and Beverage
In-kind items and services
|
Sunosi | General | $29.21 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $27.98 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $27.98 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $27.96 |
| Boehringer Ingelheim Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
OFEV | General | $27.64 |
| Grifols Shared Services North America, Inc. |
Food and Beverage
In-kind items and services
|
Prolastin-C Liquid | General | $27.23 |
| GlaxoSmithKline, LLC. |
Food and Beverage
In-kind items and services
|
NUCALA | General | $25.46 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
99215
Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
|
777 | 489 | $270.00 | $172.11 |
|
94726
Test to determine lung volumes using sensors
|
595 | 485 | $150.00 | $50.99 |
|
94729
Test to examine how well the lungs exchange gases
|
590 | 484 | $99.00 | $51.26 |
|
94060
Test to measure expiratory airflow and volume changes before and after medication administration
|
450 | 388 | $116.00 | $35.46 |
|
94010
Test to measure expiratory airflow and volume
|
240 | 212 | $67.00 | $25.19 |
|
94660
Therapy procedure using a positive pressure ventilator
|
220 | 204 | $116.00 | $60.32 |
|
99233
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes
|
208 | 101 | $206.75 | $118.93 |
|
99204
New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
|
156 | 156 | $312.00 | $159.96 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
142 | 133 | $200.00 | $117.90 |
|
J2919
Injection, methylprednisolone sodium succinate, 5 mg
|
124 | 16 | $5.32 | $0.28 |
|
G0398
Home sleep study test (hst) with type ii portable monitor, unattended; minimum of 7 channels: eeg, eog, emg, ecg/heart rate, airflow, respiratory effort and oxygen saturation
|
97 | 95 | $350.00 | $201.29 |
|
94618
Test for exercise-induced lung stress
|
84 | 81 | $123.00 | $31.82 |
|
71045
X-ray of chest, 1 view
|
62 | 54 | $60.00 | $23.75 |
|
95811
Sleep study in sleep lab with continuous airway pressure (6 years or older)
|
51 | 49 | $1500.00 | $593.94 |
|
99223
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes
|
39 | 35 | $387.00 | $175.18 |
|
96372
Injection of drug or substance under skin or into muscle
|
35 | 28 | $44.00 | $13.42 |
|
99205
New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
|
29 | 29 | $389.00 | $212.68 |
|
95810
Sleep study in sleep lab (6 years or older)
|
14 | 14 | $1358.14 | $568.81 |
|
J2920
Injection, methylprednisolone sodium succinate, up to 40 mg
|
14 | 13 | $20.00 | $4.12 |
|
31645
Aspiration of initial secretion of lung airway using an endoscope
|
11 | 11 | $250.00 | $135.58 |
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
11 | 11 | $135.00 | $72.81 |
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 440 | 21,690 | $446,579.05 | 121 |
| Montelukast Sodium | Montelukast Sodium | 283 | 20,430 | $3,177.78 | 106 |
| Prednisone | Prednisone | 217 | 5,076 | $795.29 | 142 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 197 | 5,974 | $5,946.49 | 114 |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 117 | 4,710 | $98,568.38 | 28 |
| Ofev | Nintedanib Esylate | 103 | 3,090 | $1,291,715.36 | 17 |
| Azithromycin | Azithromycin | 78 | 5,345 | $1,667.99 | 40 |
| Breo Ellipta | Fluticasone/Vilanterol | 78 | 3,930 | $48,570.26 | 25 |
| Trazodone Hcl | Trazodone Hcl | 63 | 3,390 | $887.65 | 28 |
| Pantoprazole Sodium | Pantoprazole Sodium | 37 | 2,115 | $395.07 | 17 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 37 | 1,830 | $7,347.98 | 13 |
| Fluticasone Propionate | Fluticasone Propionate | 36 | 1,920 | $431.95 | — |
| Advair Hfa | Fluticasone Propion/Salmeterol | 32 | 1,200 | $14,787.31 | 12 |
| Spiriva Respimat | Tiotropium Bromide | 31 | 2,070 | $34,192.86 | — |
| Doxycycline Hyclate | Doxycycline Hyclate | 29 | 294 | $211.74 | 27 |
| Omeprazole | Omeprazole | 27 | 1,410 | $278.32 | 12 |
| Dupixent Pen | Dupilumab | 27 | 742 | $98,456.04 | — |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 26 | 1,320 | $19,779.59 | 11 |
| Ventolin Hfa | Albuterol Sulfate | 25 | 679 | $1,493.00 | 13 |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 24 | 1,140 | $2,883.82 | — |
| Symbicort | Budesonide/Formoterol Fumarate | 23 | 1,230 | $9,788.49 | — |
| Ipratropium Bromide | Ipratropium Bromide | 21 | 648 | $793.82 | 12 |
| Stiolto Respimat | Tiotropium Br/Olodaterol Hcl | 21 | 1,050 | $17,028.11 | — |
| Famotidine | Famotidine | 19 | 1,470 | $319.40 | 15 |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 19 | 700 | $12,017.35 | — |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2021-12-21NUCC Taxonomy Code: 207RP1001X
An internist who treats diseases of the lungs and airways. The pulmonologist diagnoses and treats cancer, pneumonia, pleurisy, asthma, occupational and environmental diseases, bronchitis, sleep disorders, emphysema and other complex disorders of the lungs.
Additional State Medicaid & Healthcare Payer Identifiers
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - CRITICAL CARE (INTENSIVISTS)
I20210920000700
IN
8022003318
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File
Northwest Pulmonary And Sleep Medicine Sc
1340 Ryan Pkwy, Algonquin, IL 601024527
Phone: 8154777350
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Nurse Practitioner - Adult Health
Family Nurse Practitioner (Board Certified)
Internal Medicine
Doctor of Medicine (M.D.)
Specialist
Doctor of Medicine (M.D.), FCCP
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at 1340 RYAN PKWY, ALGONQUIN, IL 601024527 (Tel: 8154777350)
Registered at 1340 RYAN PKWY, ALGONQUIN, IL 601024527 (Tel: 8154777350)
NPI status registered as active in NPPES database
Registered at 360 STATION DR, CRYSTAL LAKE, IL 600147978 (Tel: 8154777350)
Registered at PO BOX 859, CRYSTAL LAKE, IL 600390859 (Tel: 8154777350)
Recorded as DENNIS KELLAR, MD
Internal Medicine (license number reported to NPPES: IL 036-104219)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Mailing Address
1340 Ryan Pkwy
Algonquin, IL 601024527
Phone: 8154777350